In 2023, Huadong Medicine completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Huadong Medicine has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Huadong Medicine amounted to 152,103.45 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Huadong Medicine increased by 40.06%, suggesting that the company faced challenges in reducing its emissions from its core operations.
In 2023, the total Scope 1 emissions of Huadong Medicine were 14,288.85 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2022), Huadong Medicine's Scope 1 emissions increased by 26.39%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
In 2023, Huadong Medicine reported Scope 2 greenhouse gas (GHG) emissions of 137,814.6 tCOâ‚‚e without specifying the calculation method.
Compared to the previous year (2022), Huadong Medicine's Scope 2 emissions (Unspecified Calculation Method) rose by 41.65% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
In 2023, Huadong Medicine reported its Scope 2 emissions using an unspecified methodology.